Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the […]
BIF 2024: ‘The IRA really disrupted how we think’ Read More »
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in
BIO Investor Forum opens with encouraging news on financing Read More »
There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines? Read More »
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) Investor Forum, one of the only independent partnering events dedicated to
How to follow the 2024 BIO Investor Forum in San Francisco Read More »
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics Read More »
Afreen Allam’s company, SiNON Nano Sciences, has been working tirelessly to overcome one of the most significant challenges in neurology: enabling drugs to cross
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences Read More »
Amidst Typhoon Gaemi, the Biotechnology Innovation Organization (BIO) traveled to Taipei to co-host BIO Asia-Taiwan from July 26-30. Luckily, the weather was no match
BIO travels to Taipei to co-host BIO Asia-Taiwan Read More »
Microbial ecology and its potential applications are gaining prominence in biotechnology and healthcare. Cambridge-based Concerto Biosciences is helping drive advances in this area with
NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes Read More »
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate
NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets Read More »
